Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial
PaperCitations, authors & open-access status
Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 175 citations, 2018 year and closed oa status.
175
Citations
2018
Year
closed
OA Status